scholarly journals Risk of Treatment-Related Toxicities from EGFR Tyrosine Kinase Inhibitors: A Meta-analysis of Clinical Trials of Gefitinib, Erlotinib, and Afatinib in Advanced EGFR -Mutated Non–Small Cell Lung Cancer

2017 ◽  
Vol 12 (4) ◽  
pp. 633-643 ◽  
Author(s):  
Pei Ni Ding ◽  
Sarah J. Lord ◽  
Val Gebski ◽  
Matthew Links ◽  
Victoria Bray ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document